Journal article
Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index
Eva K Fenwick, Jing Xie, Konrad Pesudovs, Julie Ratcliffe, Peggy PC Chiang, Robert P Finger, Ecosse L Lamoureux
CLINICAL AND EXPERIMENTAL OPTOMETRY | TAYLOR & FRANCIS LTD | Published : 2012
Abstract
BACKGROUND: Use of generic multi-attribute utility instruments (MAUI) to assess the impact of diabetic retinopathy (DR) on health-related quality of life (HRQoL) has produced inconsistent findings. Therefore, we assessed the impact of DR, diabetic macular oedema (DME) and associated visual impairment on vision-related QoL (VRQoL) using a vision-specific MAUI. METHODS: In this cross-sectional study, 203 diabetic patients were recruited from specialised eye clinics in a Melbourne tertiary eye hospital. Severity of combined DR/DME was categorised as: no DR/no DME, mild non-proliferative DR (NPDR) and/or mild DME; moderate NPDR and/or moderate DME and vision-threatening DR (severe NPDR or prolif..
View full abstractGrants
Awarded by National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE)
Awarded by Australian Research Council (ARC)
Funding Acknowledgements
This study was supported by the National Health and Medical Research Council Centre for Clinical Research Excellence (CCRE) #529923-Translational Clinical Research in Major Eye Diseases; CCRE Diabetes; Australian Research Council (ARC) Grant LP0884108; Royal Victorian Eye and Ear Hospital; and Operational Infrastructure Support from the Victorian Government. The funding organisations had no role in the design or conduct of this research.